XML 37 R24.htm IDEA: XBRL DOCUMENT v3.8.0.1
Revenues Revenues (Tables)
3 Months Ended
Mar. 31, 2018
Revenues [Abstract]  
Disaggregation of Revenue [Table Text Block]
Disaggregation of Revenues

The following table presents revenue disaggregated by timing of recognition and major product lines for the quarter ended March 31, 2018.

 
Topic 606 Revenue
Topic 815(1)
Total
 
Point in Time
Over Time
Total
Revenue
Revenues
Origination
 
 
 
 
 
Merchandising and Handling
$
619

$
62

$
681

$
5,479

$
6,160

Transportation

55

55


55

Total Origination
619

117

736

5,479

6,215

Oilseeds
 
 
 
 
 
Crushing and Origination
186


186

3,424

3,610

Refining, Packaging, Biodiesel, and Other
558


558

1,465

2,023

Total Oilseeds
744


744

4,889

5,633

Carbohydrate Solutions
 
 
 
 
 
Starches and Sweeteners
1,638


1,638


1,638

Bioproducts
984


984


984

Total Carbohydrate Solutions
2,622


2,622


2,622

Nutrition
 
 
 
 
 
Wild Flavors and Specialty Ingredients
636


636


636

Animal Nutrition
314


314


314

Total Nutrition
950


950


950

 
 
 
 
 
 
Other
106


106


106

Total Revenues
$
5,041

$
117

$
5,158

$
10,368

$
15,526


(1) Topic 815 revenue relates to the physical delivery or the settlement of the Company’s sales contracts that are accounted for as derivatives and are outside the scope of Topic 606.
Schedule of the financial statement transition impacts from the adoption of ASC 606 [Table Text Block]
The following tables summarize the impacts of Topic 606 adoption on the various lines of the Company’s consolidated financial statements.

Consolidated Balance Sheet (excerpt) as of March 31, 2018 and January 1, 2018
 
January 1, 2018
 
March 31, 2018
 
After Adoption
 
As
Under
Effect of
 
of Topic 606
 
Reported
Topic 605
Change
 
(In millions)
Assets
 
 
 
 
 
Trade receivables
$
2,343

 
$
2,147

$
1,752

$
395

Inventories
8,770

 
9,820

10,212

(392
)
Total Current Assets
19,918

 
20,906

20,903

3

Total Assets
$
39,956

 
$
41,100

$
41,097

$
3

Liabilities, Temporary Equity, and Shareholders’ Equity
 
 
 
 
 
Accrued expenses and other payables
$
2,826

 
$
3,035

$
3,035

$

Total Current Liabilities
12,563

 
13,285

13,285


Reinvested earnings
17,552

 
17,755

17,752

3

Total Shareholders’ Equity
18,322

 
18,737

18,734

3

Total Liabilities, Temporary Equity, and Shareholders’ Equity
$
39,956

 
$
41,100

$
41,097

$
3


Consolidated Statement of Earnings (excerpt) for the quarter ended March 31, 2018
 
 
Without
 
 
As
Adoption of
Effect of
 
Reported
Topic 606
Change
 
(In millions)
Revenues
$
15,526

$
15,536

$
(10
)
Cost of products sold
14,637

14,652

(15
)
Gross profit
889

884

5

Earnings before income taxes
464

459

5

Income taxes
68

66

2

Net earnings including noncontrolling interests
396

393

3

Net earnings attributable to controlling interests
$
393

$
390

$
3